DRTS Stock Summary and Trading Ideas (Alpha Tau Medical Ltd. - | NASDAQ:DRTS)

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.

Alpha Tau Medical Ltd. - trades on the NASDAQ stock market under the symbol DRTS.

As of December 11, 2025, DRTS stock price declined to $4.93 with 273,137 million shares trading.

DRTS has a beta of 0.81, meaning it tends to be less sensitive to market movements. DRTS has a correlation of 0.08 to the broad based SPY ETF.

DRTS has a market cap of $418.16 million. This is considered a Small Cap stock.

In the last 3 years, DRTS traded as high as $5.95 and as low as $1.75.

DRTS has outperformed the market in the last year with a price return of +62.7% while the SPY ETF gained +15.4%. DRTS has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +31.5% and +31.8%, respectively, while the SPY returned +5.9% and +1.3%, respectively.

DRTS support price is $4.82 and resistance is $5.30 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DRTS shares will trade within this expected range on the day.